The Centers for Disease Control and Prevention (CDC) released an alert Monday stating that the RSV shot for infants, Beyfortus (nirsevimab), is in limited supply. As we head into RSV season, the ...
All New Yorkers ages 75 and older should receive the RSV vaccine heading into the fall and winter months, unless they previously got the shot, according to updated federal guidance. The Centers for ...
Amid the current wave of winter respiratory virus cases, influenza (types A and B) leads the way with the highest number of emergency room visits, followed closely by COVID-19, thanks to the JN.1 ...
Respiratory syncytial virus infection (RSV) is a respiratory virus that affects most infants and toddlers by the time they turn 2 years old. It can also affect older children and adults. RSV ...
First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new. Neither is it uncommon among the youngest and oldest populations, infecting ...
In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...
Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible recipients plan to get an RSV vaccine, according to a survey conducted in ...